Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 5

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-981-14-0514-3 (Print)
ISBN: 978-981-14-0515-0 (Online)
Year of Publication: 2019
DOI: 10.2174/97898114051501190501

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer.

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. ii
Atta-ur-Rahman
Download Free

Second-Generation Protein Kinase Inhibitor – A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

- Pp. 1-21 (21)
Xavier Thomas, Etienne Paubelle
View Abstract

Physical Exercise for Cancer Patients Treated with Chemotherapy

- Pp. 22-49 (28)
Shinichiro Morishita, Atsuhiro Tsubaki, Jack B. Fu
View Abstract

Cancer Immune Evasion in Gastrointestinal Cancer: Can this be Overcome by Combination of Histone Deacetylase and Immune Checkpoint Inhibitors?

- Pp. 50-84 (35)
Yuequan Shi, Onyinyechi Duru, Zifang Zou, David Kerr
View Abstract

Long Non-Coding RNAs in Cancer Progression: Implication for Anti-Cancer Therapy

- Pp. 85-112 (28)
Chang Gong, Zihao Liu, Andrew J. Sanders, Wen G. Jiang
View Abstract

Ros-Mediated Induction of Apoptosis in Breast Cancer Cells

- Pp. 113-121 (9)
Işıl Yıldırım
View Abstract

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Battle against Drug Resistant Lung Cancer

- Pp. 122-165 (44)
Kenneth K.W. To, Wing-Sum Tong
View Abstract

Subject Index

- Pp. 166-174 (9)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Neoplasia and Fertility.
.Breast Cancer: Current Trends in Molecular Research.
.Artificial Intelligence Based Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics.
.Colorectal Cancer Diagnosis and Therapeutic Updates.